Built-in touch screen acquires images directly onto the device and transmits to PACS without a PC.
Aspenstate announced Tuesday it has received clearance from the U.S. Food & Drug Administration for its portable X-ray system, AiRTouch.
This system, developed by Aspsenstate’s parent company, Livermoretech Korea, is the first portable X-ray system on the market with a built-in touchscreen workstation. It is designed, according to a company statement, as an efficient front-line tool for acquiring chest X-rays for COVID-19 diagnoses.
Based on company information, the AiRTouch is light-weight at 5.5 lbs. Its battery fully charges within two hours and can capture up to 300 exposures during a single charge.
AiRTouch differs from other portable X-ray systems, company officials said, because it acquires images directly to the device and can wirelessly transmit them to the PACS through the machine’s built-in workstation. The built-in PC also allows for remote diagnostics and service, maximizing the functional time of the machine and eliminating the need for service calls.
To date, it has been effective in drive-through screening centers in South Korea, said David Lee, Aspenstate vice president and chief operating officer.
“Our clients have noticed a dramtic increase in capacity and the ability to move patients through quickly and efficiently,” he said in a press statement. “They find that the device is very simple to use, and the integrated software and portable features allow them to work outside of the limitations of traditional X-ray solutions.”
AiRTouch also offers other applications, including imaging for urgent care, ambulances, sports medicine, extremities, dental, veterinary, and equine purposes.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.